An Open-label, Parallel-group, Multicenter Clinical Study to Evaluate the Pharmacokinetics and Safety of SYHX1901 Tablets in Participants with Mild, Moderate Hepatic Impairment and Matched Controls with Normal Hepatic Function

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 48f341701acf83be67f3522cc2a89459d92b9d67
First added on: Sep 12, 2026